Regulatory

Nutritional Outlook’s Editorial Advisory Board members highlight potential challenges for the nutraceutical, natural product, and health and wellness industries in 2024.

California Assembly Bill 82, which bans the sale of weight management and muscle building supplements to minors, has been advanced by the Committee on Health.

Nutritional Outlook’s Editorial Advisory Board shares its predictions and tips for success in 2024.

The product is an all-natural, plant-based ingredient that can replace starches, gums, phosphates, and carrageenan, as well as enhance juiciness, flavor, and the texture of meat products.

The GlyCare 3FL 9OO1 ingredient is now approved in the EU at a higher usage level compared to other 3-FL ingredients, the company says.

The network is called Green Bridge Gateway and aims to help companies overcome hurdles of entering the UK and EU cannabinoid markets.

The claims focus on support for immune and digestive health.

The response advised Nammex that FDA has not come to a decision in the required 180 days “due to competing agency priorities,” but that the staff is evaluating the petition.

The Dr. Teal’s line of adult and kids’ melatonin-containing topical products includes a body scrub, bath soak, and moisturizer.

This means that the ingredient can be used in Brazil to fortify food and beverage products. Prior to food and beverage approval, the ingredient received ANVISA approval for retail supplement use in 2020.

Also, what to watch in 2024.

The complaint aims to have the legislation declared unconstitutional and seeks an injunctive order restraining the Attorney General’s Office from enforcing the state law.

Open Book Extracts is joined by BayMedica, Charlotte's Web, Hemp Beverage Alliance, Kazmira, Mad Tasty, and WYLD, among many others, in joining One Hemp.

The farm grows seven of the company’s ingredients: Rhodiola rosea, feverfew, nettle, flaxseed, valerian, Rhapontici radix, and lemon balm.

The Council for Responsible Nutrition has issued a statement in response to a recent research letter that the organization says raises unnecessary alarm about the pediatric use of melatonin.

TriNutra announced that its ThymoQuin ingredient has now been approved as a novel food/dietary supplement by the Thailand Food and Drug Administration.

Supplements sold in Korea containing myHMB can now make product claims about improving exercise performance.

The Council for Responsible Nutrition has announced receipt of an interim response from the U.S. Food and Drug Administration (FDA) to the Council’s recent citizen petition requesting that the agency change the way it applies the drug preclusion clause to the Food, Drug, and Cosmetic Act (FD&C Act).

The independent GRAS conclusion was done in partnership with GRAS Associates, a SGS Nutrasource company. The conclusion was submitted to FDA's GRAS notification program.

U.S. Senator Kevin Cramer (R-ND) reintroduced the bill, previously introduced as S. 1654. The bill would amend the Internal Revenue Code of 1986 to include “over-the-counter dietary supplements products and foods, for special dietary uses as qualified medical expenses.”

Steve Mister, president and CEO of the Council for Responsible Nutrition reflects on the Council's 50 years of service to the industry and what he learned from interviewing FDA commissioner Robert Califf, MD.

Nutritional Outlook’s Editor-in-Chief Jennifer Grebow interviewed the Council for Responsible Nutrition’s Steve Mister at last week’s SupplySide West trade show.

New York Governor Kathy Hochul has signed into law a bill that would restrict minors from purchasing dietary supplements marketed toward “weight loss and muscle building.”

Here’s what brands can likely expect from an updated Green Guides.

The ingredients are GlyCare 2’-fucosyllactose (2’-FL) and GlyCare lacto-N-neotetraose (LNnT).

The company’s Aequival 2’-FL is a human milk oligosaccharide ingredient that supports infants’ microbiome health.

The company recently notified FDA of the Generally Recognized as Safe (GRAS) status of its Pomella pomegranate extract. FDA responded with a letter of no objection.

An increasingly unwieldly cannabinoid industry may force Congress to take action on hemp-derived cannabinoid regulation.